Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61)
קרן | National Cancer Institute/NIH |
---|---|
מדינה | U.S.A. |
סוג | Research Grants |
תאריך אחרון | 22/09/2022 |
פקולטה | Engineering, Exact Sciences, Medicine |
תיאור | This grant solicits applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel molecular or cellular analysis capabilities for basic or clinical cancer research. The emphasis of this grant is on supporting the development of novel capabilities involving a high degree of technical innovation for targeting, probing, or assessing molecular and cellular features of cancer biology.
Funding: $150,000 per year Duration: 3 years
Research Authority due date: 10 days prior to submission LOI (encouraged) due dates: 22.3.22, 22.8.22 Full proposal due dates: 22.4.22, 22.9.22
|
קבצים מצורפים | |
קישור | לאתר |
עדכון אחרון | עדכון אחרון: 25/11/2021 |